Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome
Open accessThe DOI matches its Crossref record; 36 of the 37 references it cites were found in a registry or an index.
Abstract
BACKGROUND/AIMS: Dysbiosis is associated with various systemic disorders including irritable bowel syndrome (IBS). Fecal microbiota transplantation (FMT) might restore intestinal microbial balance. The study aimed to determine the safety and efficacy of FMT in IBS patients, as well as also positive predictors for FMT. METHODS: This was a single-arm, open-label study. Eligible patients were diagnosed based on Rome III Diagnostic Criteria. Fecal materials were administered to the patient via colonoscopy. The primary end point was a change in the Bristol stool form scale at 4 weeks after FMT. Recovery to types 3-4 was considered a clinical response. The secondary end point was a change in intestinal microbiota and psychological status using the Hamilton Rating Scale. RESULTS: Ten patients were enrolled. Six patients achieved a clinical response. The diversity of patients 4 weeks after FMT increased significantly compared with patients before FMT, and that of responding patients was significantly higher than non-responder patients. The abundance of Bifidobacterium in effective donors was significantly higher than in ineffective donors and patients. Psychological status of all patients was significantly improved after FMT. CONCLUSIONS: FMT for patients with IBS is safe, and relatively effective. Bifidobacterium-rich fecal donor may be a positive predictor for successful FMT. Key Summary: (1) Dysbiosis is associated with various gastrointestinal disorders including IBS. (2) FMT has potential to restore intestinal microbial balance. (3) We showed that FMT improved stool form and psychological status of IBS patients. (4) Bifidobacterium-rich donor efficiently induced symbiosis in IBS patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Mizuno et al. [90] in open-label, non-randomized, single-center trials found that psychiatric status of IBS patients, assessed using the Hamilton Rating Scale for Depression (HAMD), was significantly improved at 1 month after FMT from healthy donors, but returned to the baseline level after 12 weeks.”
From The Role of Microbiota-Gut-Brain Axis in Neuropsychiatric and Neurological Disorders (2021) · cites this paper as [90]
In the citing paper
“Three of the four studies found a significant improvement in anxiety symptoms following FMT [44, 45, 48].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [44]
In the citing paper
“The long-term effects were less consistent, with three studies finding a return to baseline at week 12, week 20, and month 6 respectively [44–46].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [44]
In the citing paper
“Although Mizuno et al. found improvement in the anxiety scores as well, it was not significant [44].”
From Effect of fecal microbiota transplant on symptoms of psychiatric disorders: a systematic review (2020) · cites this paper as [44]
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Longstreth, G. F., Thompson, W. G., Chey, W. D., Houghton, L. A., Mearin, F., & Spiller, R. C. (2006) · Gastroenterology · doi:10.1053/j.gastro.2005.11.061 · Cited by 4,856
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
Stool form scale as a useful guide to intestinal transit time
Lewis, S. J., & Heaton, K. W. (1997) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529709011203 · Cited by 3,244
Gut/brain axis and the microbiota
Mayer, E. A., Tillisch, K., & Gupta, A. (2015) · Journal of Clinical Investigation · doi:10.1172/jci76304 · Cited by 1,503
Moayyedi, P., Surette, M. G., Kim, P. T., Libertucci, J., Wolfe, M., Onischi, C., Armstrong, D., Marshall, J. K., Kassam, Z., Reinisch, W., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.001 · Cited by 1,499
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome
Halmos, E. P., Power, V. A., Shepherd, S. J., Gibson, P. R., & Muir, J. G. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.09.046 · Cited by 1,249
Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002
Cited by
Items 301–400 of 410
Matsuoka, H., Tochio, T., Watanabe, A., Funasaka, K., Hirooka, Y., Hartanto, T., Togashi, Y., Saito, M., Nishimoto, Y., Mizuguchi, Y., et al. (2022) · Foods · doi:10.3390/foods11040549 · Cited by 9
Sato, S., Iino, C., Sasada, T., Soma, G., Furusawa, K., Yoshida, K., Sawada, K., Mikami, T., Nakaji, S., Sakuraba, H., et al. (2024) · Genes · doi:10.3390/genes15091172 · Cited by 8
Vitamin K intake and health, consideration from the epidemiological studies
Kuwabara, A., Uenishi, K., & Tanaka, K. (2021) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.20-64 · Cited by 8
Exploring clade differentiation of the Faecalibacterium prausnitzii complex
Fabbrini, M., Candela, M., Turroni, S., Brigidi, P., & Rampelli, S. (2022) · iScience · doi:10.1016/j.isci.2022.105533 · Cited by 8
Miyayama, C., Morisaki, N., Ogawa, K., Tanaka, H., Shoji, H., Shimizu, T., Sago, H., Horikawa, R., & Urayama, K. Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-45316-8 · Cited by 8
Tsukimi, T., Obana, N., Shigemori, S., Arakawa, K., Miyauchi, E., Yang, J., Song, I., Ashino, Y., Wakayama, M., Soga, T., et al. (2024) · mSystems · doi:10.1128/msystems.01123-23 · Cited by 8
Li, J., Xue, H., Qingqing, M., He, X., Ma, L., Shi, B., Sun, S., & Yao, X. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.576445 · Cited by 8
Regional Diets Targeting Gut Microbial Dynamics to Support Prolonged Healthspan
Low, D. Y., Hejndorf, S., Tharmabalan, R. T., Poppema, S., & Pettersson, S. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.659465 · Cited by 8
Microbe‐associated metabolites as targets for incident type 2 diabetes
Hashimoto, Y., Hamaguchi, M., & Fukui, M. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13424 · Cited by 8
Koguchi, H., Ishigami, N., Sakanaka, M., Yoshida, K., Hiratou, S., Shimada, M., Fukiya, S., Sonoyama, K., & Yokota, A. (2020) · Microorganisms · doi:10.3390/microorganisms8030410 · Cited by 8
Guo, X., Zhu, Y.-L., Yang, L., Li, W., & Du, X.-F. (2022) · Infection and Drug Resistance · doi:10.2147/idr.s385485 · Cited by 7
Imoto, N., Kano, C., Morita, H., Hirota, T., Amanuma, F., Maruyama, H., Nojiri, S., & Watanabe, S. (2025) · BMC Microbiology · doi:10.1186/s12866-025-04056-7 · Cited by 7
Microbiome–Gut Dissociation: Investigating the Origins of Obesity
Smith, D. G., & Jheeta, S. (2021) · Gastrointestinal Disorders · doi:10.3390/gidisord3040017 · Cited by 7
“To illustrate the problems inherent within this new field, the bifidobacteria are a class of promising microbes, with attempts being made to cure irritable bowel syndrome by faecal microbiota transplantation [69], or at least to control the pain of this disease, though apparently with limited success [70].”
BackgroundNoorafshan, A., Yousefi, M., Hosseini, L., & Karbalay‐Doust, S. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05600-y · Cited by 7
Succession of the intestinal bacterial community in Pacific bluefin tuna (Thunnus orientalis) larvae
Taniguchi, A., Aoki, R., Inoue, I., & Eguchi, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275211 · Cited by 7
A Microbial Relationship Between Irritable Bowel Syndrome and Depressive Symptoms
Perez, N. B., Wright, F., & Vorderstrasse, A. A. (2020) · Biological Research For Nursing · doi:10.1177/1099800420940787 · Cited by 7
Takayasu, L., Suda, W., Watanabe, E., Fukuda, S., Takanashi, K., Ohno, H., Takayasu, M., Takayasu, H., & Hattori, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180863 · Cited by 7
Self-citationCharacterization of gut microbiota dysbiosis in breast cancer patients
Yamada, M., Kubo, M., Kaneshiro, K., Kai, M., Morisaki, T., Hayashi, S., Ochiai, Y., Sato, Y., Mizoguchi, K., Takao, Y., et al. (2025) · Breast Cancer · doi:10.1007/s12282-025-01782-8 · Cited by 6
OMARU: a robust and multifaceted pipeline for metagenome-wide association study
Kishikawa, T., Tomofuji, Y., Inohara, H., & Okada, Y. (2022) · NAR Genomics and Bioinformatics · doi:10.1093/nargab/lqac019 · Cited by 6
Gut Microbiota Associated with Clinical Relapse in Patients with Quiescent Ulcerative Colitis
Kitae, H., Takagi, T., Naito, Y., Inoüe, R., Azuma, Y., Torii, T., Mizushima, K., Doi, T., Inoue, K., Dohi, O., et al. (2022) · Microorganisms · doi:10.3390/microorganisms10051044 · Cited by 6
Gut Microbes: The Gut Brain Connection
Lynch, C. M. K., O’Riordan, K. J., Clarke, G. A., & Cryan, J. F. (2023) · Springer eBooks · doi:10.1007/978-3-031-46712-7_4 · Cited by 6
Lessons Learned from Faecal Microbiota Transplantation in Cirrhosis
Hatton, G. B., Ran, S., Tranah, T. H., & Shawcross, D. L. (2020) · Current Hepatology Reports · doi:10.1007/s11901-020-00520-2 · Cited by 6
Nieuwenhove, T. V., Rasschaert, G., Kharagjitsingh, A. V., Keymeulen, B., Reynaert, H., & Kindt, S. (2021) · Acta gastro-enterologica belgica · doi:10.51821/84.4.003 · Cited by 6
Trinh, S., Keller, L., Herpertz‐Dahlmann, B., & Seitz, J. (2023) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000928 · Cited by 5
Toda, K., Yoshimoto, S., Yoshida, K., Mitsuyama, E., Iwabuchi, N., Hosomi, K., Jujo, T., Tanaka, M., Nanri, H., Kunisawa, J., et al. (2024) · Microorganisms · doi:10.3390/microorganisms12040781 · Cited by 5
Establishment of enterotype-specific antibodies for various diagnostic systems
Yoshii, K., Node, E., Furuta, M., Tojima, Y., Matsunaga, A., Adachi, J., Takaai, N., Morita, M., Hosomi, K., & Kunisawa, J. (2025) · Scientific Reports · doi:10.1038/s41598-025-01144-6 · Cited by 5
Gut Microbiota and Interorgan Communication Among the Gut, Brain, and Beyond
Shigehara, A., Kiyohara, H., Teratani, T., Nakamoto, N., Mikami, Y., & Kanai, T. (2025) · Internal Medicine · doi:10.2169/internalmedicine.5318-25 · Cited by 5
Self-citationLin, H., Feng, Z., Tu, Q., Huizhen, L. I., Zhang, Y., Wei, X., Yi, Q., Zhang, H., Wang, Y., Li, X., et al. (2026) · Microbial Biotechnology · doi:10.1111/1751-7915.70323 · Cited by 5
“Poor initial responders with IBS may benefit from additional treatments or higher doses (Holvoet et al. 2021), and structured FMT in ASD has led to sustained behavioural improvement and microbial stability (Kang et al. 2019).”
InfluentialTemyingyong, N., Koonrungsesomboon, N., Hanprasertpong, N., Takuathung, M. N., & Teekachunhatean, S. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/7192326 · Cited by 5
Characteristics of the Gut Microbiota in Japanese Patients with Premenstrual Syndrome
Okuma, K., Kono, K., Otaka, M., Ebara, A., Odachi, A., Tokuno, H., & Masuyama, H. (2022) · International Journal of Women s Health · doi:10.2147/ijwh.s377066 · Cited by 5
Shijimaya, T., Tahara, T., Yamazaki, J., Kobayashi, S., Matsumoto, Y., Nakamura, N., Takahashi, Y., Tomiyama, T., Fukui, T., Shibata, T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-67410-1 · Cited by 5
Self-citationSeasonal variations in gut microbiota and disease course in patients with inflammatory bowel disease
Tani, M., Shinzaki, S., Asakura, A., Tashiro, T., Amano, T., Otake, Y., Yoshihara, T., Yoshii, S., Tsujii, Y., Hayashi, Y., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283880 · Cited by 5
Devi, M. B., Sarma, H. K., Mukherjee, A. K., & Khan, M. R. (2023) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-023-10087-1 · Cited by 5
Differences in gut microbial patterns associated with salivary biomarkers in young Japanese adults
Seura, T., & Fukuwatari, T. (2020) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2019-034 · Cited by 5
Parabacteroides absconsus sp. nov., isolated from feces of a child with atopic dermatitis
Chaplin, A. V., Pikina, A. P., Shcherbakova, V. A., Sokolova, S. R., Podoprigora, I. V., Sergueïevna, D. M., Александрович, К. Ф., Ilyina, G. A., Vasiliadis, I. A., & Efimov, B. A. (2025) · Archives of Microbiology · doi:10.1007/s00203-024-04221-y · Cited by 4
Hasegawa, M., Kawaguchi, T., Kiyohara, H., Teratani, T., Nakamoto, N., Mikami, Y., & Kanai, T. (2025) · Immunological Medicine · doi:10.1080/25785826.2025.2604347 · Cited by 4
“In human irritable bowel syndrome (IBS), fecal microbiota transplantation improves gastrointestinal symptoms and depressive symptoms [147].”
Self-citationBarbosa, J. A., Parra-Aguirre, J. C., Nosach, R., Harding, J. C. S., Cantarelli, V. S., & Costa, M. D. O. (2023) · PLoS ONE · doi:10.1371/journal.pone.0294273 · Cited by 4
Caserta, S., Alvaro, M. E., Penna, G., Fazio, M., Stagno, F., & Allegra, A. (2025) · Biomedicines · doi:10.3390/biomedicines13092141 · Cited by 4
“While direct evidence of their impact on NHL outcomes remains limited, dietary modulation may represent a supportive measure for maintaining gut eubiosis during treatment [57,58].”
Changes in the intestinal microbiota of Japanese children during the first 3.5 years of life
Tsuruoka, Y., Kato, T., Watanabe, M., Taguchi‐Atarashi, N., Ohno, H., Mori, C., & Sakurai, K. (2024) · Scientific Reports · doi:10.1038/s41598-024-78844-y · Cited by 4
Gut microbial stability in older Japanese populations: insights from the Mykinso cohort
Watanabe, S., Yoshida, N., Baba, K., Yamasaki, H., Shinozaki, N. O., Ogawa, M., Yamashita, T., & Takeda, A. (2023) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2022-047 · Cited by 4
Irritable bowel syndrome and the gut microbiota
Heenan, P. E., Keenan, J. I., Bayer, S. B., Simon, M., & Gearry, R. B. (2019) · Journal of the Royal Society of New Zealand · doi:10.1080/03036758.2019.1695635 · Cited by 4
“…the 1980s (Borody et al. 1989), inter-study heterogeneity with regards to methodology, screening of faecal microbial donors, and the subtype of IBS patients as well as a lack of long term follow-up have led to inconsistent findings (Aguilar et al. 2015; Mazzawi et al. 2016; Mizuno et al. 2017).”
ResultMapping the Environmental Microbiome
Takayasu, L., Suda, W., & Hattori, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809633-8.20071-x · Cited by 4
Self-citationExposure and resistance to lantibiotics impact microbiota composition and functionPreprint
Zhang, Z. J., Cole, C. G., Lin, H., Wu, C., Haro, F., McSpadden, E., van der Donk, W. A., & Pamer, E. G. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.30.573728 · Cited by 4
Towards a Generative Paradigm for Large-scale Microbiome Analysis by Generative Language ModelPreprint
Zhang, H., Kang, Z., Zhang, Y., Yang, R., & Ning, K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.15.633278 · Cited by 4
Yamane, T., Masaoka, T., Ishii, C., Masuoka, H., Suda, W., Kurokawa, S., Kishimoto, T., Mikami, Y., Fukuda, S., & Kanai∥, T. (2025) · Digestion · doi:10.1159/000545183 · Cited by 3
Self-citationArif, T. B., Damianos, J., Rahman, A., & Hasnain, N. (2025) · Current Gastroenterology Reports · doi:10.1007/s11894-025-01001-6 · Cited by 3
“Similarly, changes in the Bristol Stool Form Scale (BSFS) [92] and improvement of IBS symptoms after a specific period were also considered adequate clinical responses in other studies [90, 95, 97, 98, 102, 104, 110, 135, 136].”
Das, K., Upadhyay, S., & Oli, S. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99988-5.00021-8 · Cited by 3
Watai, K., Suda, W., Kurokawa, R., Sekiya, K., Hayashi, H., Iwata, M., Nagayama, K., Nakamura, Y., Hamada, Y., Kamide, Y., et al. (2024) · BMC Microbiology · doi:10.1186/s12866-024-03239-y · Cited by 3
Self-citationPower calculations for detecting differences in efficacy of fecal microbiota donors
Olesen, S. W. (2020) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2020.100674 · Cited by 3
“30 Others have tested for the possibility that donors with greater microbiota diversity, or a differential 31 abundance of some microbial taxon, is more efficacious [14, 15, 16, 17, 18].”
BackgroundSmith, D. A., Palacios-Pérez, M., & Jheeta, S. (2022) · Gastrointestinal Disorders · doi:10.3390/gidisord4030012 · Cited by 3
The Influence of Microbiota on Gastrointestinal Motility
Raja, S. M., Batra, V., & Srinivasan, S. (2018) · Springer eBooks · doi:10.1007/978-1-4939-7534-1_6 · Cited by 3
Hamblin, H. S., Gunaratne, A. W., Clancy, A. K., Pilarinos, D., Busque, A. L., Dawson, M. V. M., & Borody, T. J. (2022) · Gastroenterology Research and Practice · doi:10.1155/2022/6083896 · Cited by 3
Different maturation of gut microbiome in Korean children
Kim, J., Kim, E. J., Kim, B., Kim, J., Lee, H. J., Park, J.-S., Hwang, S., Rho, M., & Pai, H. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.1036533 · Cited by 2
Mir, G. J., & Ashraf, N. U. (2024) · The International Journal of Gastroenterology and Hepatology Diseases · doi:10.2174/0126662906299478240614100954 · Cited by 2
Microbiome and In Vitro Gut Models
Hushpulian, D. M., Nikulin, S. V., Zakhariants, A. A., Сергеевич, С. С., & Tishkov, V. I. (2024) · Applied Biochemistry and Microbiology · doi:10.1134/s0003683824700261 · Cited by 2
Penton, C. R., & Vadakattu, G. (2026) · PNAS Nexus · doi:10.1093/pnasnexus/pgag132 · Cited by 2
“FMT has also been used to significantly ameliorate depression and anxiety symptoms (275) with a meta-analysis (276) finding significant short-term improvement in depression, though long-term effects were less consistent (277, 278).”
Gut Microbiome and Gastrointestinal Disorders
Legaki, E., Karanasou, E. A., & Gazouli, M. (2021) · The microbiomes of humans, animals, plants, and the environment · doi:10.1007/978-3-030-59642-2_3 · Cited by 2
Fukuoka, T., Yamamoto, S., Honma, K., Fujii, M., Nakayama, H., Kirihara, S., Gotoh, K., Tsuji, S., Kawai, Y., Tago, H., et al. (2025) · Folia Microbiologica · doi:10.1007/s12223-025-01283-3 · Cited by 2
Diet in irritable bowel syndrome
Sienkiewicz, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821324-7.00013-7 · Cited by 2
Lai, H., & Shen, T. (2023) · Healthy ageing and longevity · doi:10.1007/978-3-031-14023-5_14 · Cited by 1
Cho, Y. (2019) · Intestinal Research · doi:10.5217/ir.2018.00171 · Cited by 1
Fecal microbiota transplantation for treatment of irritable bowel syndrome
Halkjær, S. I., Lo, B. Z. S., Cold, F., Christensen, A. H., Gluud, L. L., & Petersen, A. M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013602 · Cited by 1
Higashinakagawa, T., Kikuchi, H., & Kuwayama, H. (2021) · PLoS ONE · doi:10.1371/journal.pone.0259297 · Cited by 1
Shoji, F., Miura, N., Tagawa, T., Tsukamoto, S., Okamoto, T., Yamazaki, K., Hamatake, M., & Takeo, S. (2022) · Thoracic Cancer · doi:10.1111/1759-7714.14640 · Cited by 1
CE: Current and Emerging Applications of Fecal Microbiota Transplantation
Baker, K. A., & Poole, C. (2023) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000978920.88346.77 · Cited by 1
“Another study by Mizuno and colleagues noted that six of 10 subjects with IBS achieved a clinical response to FMT, and an increase in microbiota diversity was noted four weeks later.(57) A recent meta-analysis of seven randomized controlled trials with a total of 472 subjects with IBS, however, noted that the quality…”
BackgroundGhasemzadeh, Y. (2024) · Qapsule Queen s Undergraduate Health Sciences Journal · doi:10.24908/qap.v1i2.17348 · Cited by 1
Liu, J., Huang, Y., Fu, X., Wei, J., & Wei, P. (2024) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s485504 · Cited by 1
Eun, C. S. (2017) · Intestinal Research · doi:10.5217/ir.2017.15.2.145 · Cited by 1
Oliphant, K. (2018) · The Atrium (University of Guelph) · Cited by 1
Deciphering the role of microbially-derived metabolites on the microbiota-gut-brain axis
Spichak, S. (2021) · Arrow@dit (Dublin Institute of Technology) · Cited by 1
Palani, D., Bapatdhar, N., Manchiraju, R., Kumar, B. P., Ghosh, S., & Palaniappan, S. K. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.21.600147 · Cited by 1
Transplante de microbiota fecal
Montez, J. R. C. (2018) · Repositório Comum (Repositório Científico de Acesso Aberto de Portugal) · Cited by 1
Current Status and Future Perspective of Fecal Microbiota Transplantation
Mizuno, S., & Kanai∥, T. (2018) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.107.2176
Self-citationTreatment of Chronic Constipation (Constipation and Intestinal Flora)
Osaki, H., Jodai, Y., Kamano, T., Funasaka, K., Nagasaka, M., Nakagawa, Y., Shibata, T., & Ohmiya, N. (2019) · Nihon Daicho Komonbyo Gakkai Zasshi · doi:10.3862/jcoloproctology.72.609
慎大, 水. (2019) · 日本生物学的精神医学会誌 = Japanese journal of biological psychiatry · doi:10.11249/jsbpjjpp.30.2_45
Концепция супердонора и другие возможные факторы эффективности трансплантации фекальной микробиоты
Ткач, С. М., Dorofeev, A. E., & Kuzenko, Y. G. (2020) · GASTROENTEROLOGY · doi:10.22141/2308-2097.54.3.2020.211740
Zhang, C. (2021) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/85829
Emerging Role of Gut Microbiota in Functional Gastrointestinal Disorders
Augustine, P., Ghoshal, U. C., Rizwan Ahamed, Z., & Philips, C. A. (2022) · Springer eBooks · doi:10.1007/978-981-16-7672-7_3
Nakajima, A., Yoshida, K., Gotoh, A., Katoh, T., Ojima, M. N., Sakanaka, M., Xiao, J., Odamaki, T., & Katayama, T. (2022) · Microbiome Research Reports · doi:10.20517/mrr.2022.08
Possible factors determining efficacy of fecal microbiota transplantation. Review
Ткач, С. М., Kharchenko, N. V., & Dorofeev, A. E. (2022) · Modern Gastroenterology · doi:10.30978/mg-2022-1-48
Kuronuma, K., Susai, N., Kuroita, T., Yoshioka, T., Saito, A., & Chiba, H. (2023) · Bioscience of Microbiota Food and Health · doi:10.12938/bmfh.2022-042
Zhou, C., Yi, Y., Taishi, Y., Wang, L., & Qu, J. (2023) · Research Square · doi:10.21203/rs.3.rs-3090202/v1
Liu, X., & Wu, S. (2023) · World Chinese Journal of Digestology · doi:10.11569/wcjd.v31.i22.922
Fecal Microbiota Transplantation for Treatment of Irritable Bowel Syndrome
Yamane, T., Masaoka, T., & Kanai∥, T. (2024) · Springer eBooks · doi:10.1007/978-981-97-8410-3_17
Self-citationSaito, Y., & Sagae, T. (2025) · Scientific Reports · doi:10.1038/s41598-025-86273-8
An Intestinal Metabolite Exacerbates Stress-induced Diarrhea
Ishihara, N., Kimura, S., & Hase, K. (2025) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.24-00190-2
Mifsud, M. M. (2025) · Undergraduate Research in Natural and Clinical Science and Technology (URNCST) Journal · doi:10.26685/urncst.905
Jha, A., Krishnamoorthy, G., & Narayana, A. I. (2025) · F1000Research · doi:10.12688/f1000research.169788.1
Hamazaki, M., Sawada, T., Yamamura, T., Maeda, K., Mizutani, Y., Ishikawa, E., Furune, S., Yamamoto, K., Ishikawa, T., Kakushima, N., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20317520
Hamazaki, M., Sawada, T., Yamamura, T., Maeda, K., Mizutani, Y., Ishikawa, E., Furune, S., Yamamoto, K., Ishikawa, T., Kakushima, N., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20317526
Hamazaki, M., Sawada, T., Yamamura, T., Maeda, K., Mizutani, Y., Ishikawa, E., Furune, S., Yamamoto, K., Ishikawa, T., Kakushima, N., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20317532
Yang, C., Hu, T., Xue, X., Su, X., Zhang, X., Fan, Y., Shen, X., & Dong, X. (2023) · Figshare · doi:10.6084/m9.figshare.24761295
Yang, C., Hu, T., Xue, X., Su, X., Zhang, X., Fan, Y., Shen, X., & Dong, X. (2024) · Figshare · doi:10.6084/m9.figshare.26650659
Hamazaki, M., Sawada, T., Yamamura, T., Maeda, K., Mizutani, Y., Ishikawa, E., Furune, S., Yamamoto, K., Ishikawa, T., Kakushima, N., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20317523
Yang, C., Hu, T., Xue, X., Su, X., Zhang, X., Fan, Y., Shen, X., & Dong, X. (2024) · Figshare · doi:10.6084/m9.figshare.26650656
Hamazaki, M., Sawada, T., Yamamura, T., Maeda, K., Mizutani, Y., Ishikawa, E., Furune, S., Yamamoto, K., Ishikawa, T., Kakushima, N., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20317529
Yang, C., Hu, T., Xue, X., Su, X., Zhang, X., Fan, Y., Shen, X., & Dong, X. (2024) · Figshare · doi:10.6084/m9.figshare.26650662
Metadata
- Authors
- Mizuno, S., Masaoka, T., Naganuma, M., Kishimoto, T., Kitazawa, M., Kurokawa, S., Nakashima, M., Takeshita, K., Suda, W., Mimura, M., Hattori, M., & Kanai, T.
- Affiliations
- Keio University (JP)
- Waseda University (JP)
- ORCID
- Venue
- Digestion
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 96
- Issue
- 1
- Pages
- 29-38
- ISSN
- 0012-2823 (ISSN-L)
- 1421-9867
- PMC
- PMC5637308
- OpenAlex
- W2657252452
- Cited by
- 395
- References
- 37
- Citations by year
- 2026: 7 · 2025: 28 · 2024: 34 · 2023: 52 · 2022: 76 · 2021: 46 · 2020: 45 · 2019: 41 · 2018: 38 · 2017: 19
- FWCI
- 41.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor)
- creativecommons.org/licenses/by-nc-nd/4.0/ (tdm)
- Locations
- Digestion (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Tokyo Medical and Dental University
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- fecal microbiota transplantation, irritable bowel syndrome, Bifidobacterium, donor selection, predictors of treatment response, gut dysbiosis, stool consistency, psychological state, Hamilton Depression Rating Scale, gut microbiota diversity
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Adult, Bifidobacterium, Colonoscopy, Feces, Female, Humans, Intestines, Japan, Male, Middle Aged, Treatment Outcome, Living Donors, Irritable Bowel Syndrome, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.